Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

GnRH Agonist Improves Hyperandrogenism in an Adolescent Girl With an Insulin Receptor Gene Mutation.

Paprocki E, Barral RL, Vanden Brink H, Lujan M, Burgert TS.

J Endocr Soc. 2019 May 7;3(6):1196-1200. doi: 10.1210/js.2019-00045. eCollection 2019 Jun 1.

2.

Ovarian Morphology by Transabdominal Ultrasound Correlates With Reproductive and Metabolic Disturbance in Adolescents With PCOS.

Rackow BW, Vanden Brink H, Hammers L, Flannery CA, Lujan ME, Burgert TS.

J Adolesc Health. 2018 Mar;62(3):288-293. doi: 10.1016/j.jadohealth.2017.09.005. Epub 2017 Dec 6.

PMID:
29217212
3.

Distinct Functions for Anterograde and Retrograde Sorting of SORLA in Amyloidogenic Processes in the Brain.

Dumanis SB, Burgert T, Caglayan S, Füchtbauer A, Füchtbauer EM, Schmidt V, Willnow TE.

J Neurosci. 2015 Sep 16;35(37):12703-13. doi: 10.1523/JNEUROSCI.0427-15.2015.

4.

Lysosomal sorting of amyloid-β by the SORLA receptor is impaired by a familial Alzheimer's disease mutation.

Caglayan S, Takagi-Niidome S, Liao F, Carlo AS, Schmidt V, Burgert T, Kitago Y, Füchtbauer EM, Füchtbauer A, Holtzman DM, Takagi J, Willnow TE.

Sci Transl Med. 2014 Feb 12;6(223):223ra20. doi: 10.1126/scitranslmed.3007747.

5.

SORLA-dependent and -independent functions for PACS1 in control of amyloidogenic processes.

Burgert T, Schmidt V, Caglayan S, Lin F, Füchtbauer A, Füchtbauer EM, Nykjaer A, Carlo AS, Willnow TE.

Mol Cell Biol. 2013 Nov;33(21):4308-20. doi: 10.1128/MCB.00628-13. Epub 2013 Sep 3.

6.

The pro-neurotrophin receptor sortilin is a major neuronal apolipoprotein E receptor for catabolism of amyloid-β peptide in the brain.

Carlo AS, Gustafsen C, Mastrobuoni G, Nielsen MS, Burgert T, Hartl D, Rohe M, Nykjaer A, Herz J, Heeren J, Kempa S, Petersen CM, Willnow TE.

J Neurosci. 2013 Jan 2;33(1):358-70. doi: 10.1523/JNEUROSCI.2425-12.2013.

7.

Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI.

Flannery CA, Rackow B, Cong X, Duran E, Selen DJ, Burgert TS.

Pediatr Diabetes. 2013 Feb;14(1):42-9. doi: 10.1111/j.1399-5448.2012.00902.x. Epub 2012 Aug 28.

8.

Short-term metabolic and cardiovascular effects of metformin in markedly obese adolescents with normal glucose tolerance.

Burgert TS, Duran EJ, Goldberg-Gell R, Dziura J, Yeckel CW, Katz S, Tamborlane WV, Caprio S.

Pediatr Diabetes. 2008 Dec;9(6):567-76. doi: 10.1111/j.1399-5448.2008.00434.x. Epub 2008 Aug 27.

PMID:
18761646
9.

High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype.

Taksali SE, Caprio S, Dziura J, Dufour S, Calí AM, Goodman TR, Papademetris X, Burgert TS, Pierpont BM, Savoye M, Shaw M, Seyal AA, Weiss R.

Diabetes. 2008 Feb;57(2):367-71. Epub 2007 Oct 31.

10.

Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial.

Savoye M, Shaw M, Dziura J, Tamborlane WV, Rose P, Guandalini C, Goldberg-Gell R, Burgert TS, Cali AM, Weiss R, Caprio S.

JAMA. 2007 Jun 27;297(24):2697-704.

PMID:
17595270
11.

Degree of obesity and glucose allostasis are major effectors of glucose tolerance dynamics in obese youth.

Weiss R, Cali AM, Dziura J, Burgert TS, Tamborlane WV, Caprio S.

Diabetes Care. 2007 Jul;30(7):1845-50. Epub 2007 May 2.

PMID:
17475938
12.

Glucose and insulin metabolism in obese youth.

Burgert TS.

Pediatr Endocrinol Rev. 2006 Dec;3 Suppl 4:555-9. Review.

PMID:
17237742
13.

Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome.

Winer JC, Zern TL, Taksali SE, Dziura J, Cali AM, Wollschlager M, Seyal AA, Weiss R, Burgert TS, Caprio S.

J Clin Endocrinol Metab. 2006 Nov;91(11):4415-23. Epub 2006 Aug 22.

PMID:
16926246
14.

Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat.

Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, Constable RT, Weiss R, Tamborlane WV, Savoye M, Seyal AA, Caprio S.

J Clin Endocrinol Metab. 2006 Nov;91(11):4287-94. Epub 2006 Aug 15.

PMID:
16912127
15.

Ethnic differences in beta cell adaptation to insulin resistance in obese children and adolescents.

Weiss R, Dziura JD, Burgert TS, Taksali SE, Tamborlane WV, Caprio S.

Diabetologia. 2006 Mar;49(3):571-9. Epub 2006 Feb 3.

PMID:
16456682
16.

Microalbuminuria in pediatric obesity: prevalence and relation to other cardiovascular risk factors.

Burgert TS, Dziura J, Yeckel C, Taksali SE, Weiss R, Tamborlane W, Caprio S.

Int J Obes (Lond). 2006 Feb;30(2):273-80.

PMID:
16231019
17.

Predictors of changes in glucose tolerance status in obese youth.

Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S.

Diabetes Care. 2005 Apr;28(4):902-9.

PMID:
15793193
18.

The normal glucose tolerance continuum in obese youth: evidence for impairment in beta-cell function independent of insulin resistance.

Yeckel CW, Taksali SE, Dziura J, Weiss R, Burgert TS, Sherwin RS, Tamborlane WV, Caprio S.

J Clin Endocrinol Metab. 2005 Feb;90(2):747-54. Epub 2004 Nov 2.

PMID:
15522932
19.

Obesity and the metabolic syndrome in children and adolescents.

Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S.

N Engl J Med. 2004 Jun 3;350(23):2362-74.

20.

Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents.

Yeckel CW, Weiss R, Dziura J, Taksali SE, Dufour S, Burgert TS, Tamborlane WV, Caprio S.

J Clin Endocrinol Metab. 2004 Mar;89(3):1096-101.

PMID:
15001593
21.

Assessing insulin resistance: application of a fasting glucose to insulin ratio in growth hormone-treated children.

Burgert TS, Vuguin PM, DiMartino-Nardi J, Attie KM, Saenger P.

Horm Res. 2002;57(1-2):37-42.

PMID:
12006718
22.

Prenatal genetic carrier testing using triple disease screening.

Eng CM, Schechter C, Robinowitz J, Fulop G, Burgert T, Levy B, Zinberg R, Desnick RJ.

JAMA. 1997 Oct 15;278(15):1268-72.

PMID:
9333269
23.

Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes.

Eng CM, Ashley GA, Burgert TS, Enriquez AL, D'Souza M, Desnick RJ.

Mol Med. 1997 Mar;3(3):174-82.

24.

Fabry disease: twenty-three mutations including sense and antisense CpG alterations and identification of a deletional hot-spot in the alpha-galactosidase A gene.

Eng CM, Niehaus DJ, Enriquez AL, Burgert TS, Ludman MD, Desnick RJ.

Hum Mol Genet. 1994 Oct;3(10):1795-9.

PMID:
7531540

Supplemental Content

Loading ...
Support Center